Mubritinib API Manufacturers

compare suppliers & get competitive offers

teaser-1024x654-1
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Mubritinib is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Mubritinib or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Mubritinib API 366017-09-6?

Description:
Here you will find a list of producers, manufacturers and distributors of Mubritinib. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Mubritinib 
Synonyms:
 
Cas Number:
366017-09-6 
DrugBank number:
DB12682 
Unique Ingredient Identifier:
V734AZP9BR

General Description:

Mubritinib, identified by CAS number 366017-09-6, is a notable compound with significant therapeutic applications. Mubritinib has been used in trials studying the treatment of Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm.

Classification:

Mubritinib belongs to the class of organic compounds known as phenylbutylamines. These are compounds containing a phenylbutylamine moiety, which consists of a phenyl group substituted at the fourth carbon by an butan-1-amine, classified under the direct parent group Phenylbutylamines. This compound is a part of the Organic compounds, falling under the Benzenoids superclass, and categorized within the Benzene and substituted derivatives class, specifically within the Phenylbutylamines subclass.